Matthew I Milowsky

Matthew I Milowsky

UNVERIFIED PROFILE

Are you Matthew I Milowsky?   Register this Author

Register author
Matthew I Milowsky

Matthew I Milowsky

Publications by authors named "Matthew I Milowsky"

Are you Matthew I Milowsky?   Register this Author

100Publications

2394Reads

39Profile Views

Perioperative systemic therapy for bladder cancer.

Curr Opin Urol 2019 May;29(3):220-226

Division of Hematology/Oncology, Department of Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOU.0000000000000600DOI Listing
May 2019

Modelling cost-effectiveness of a biomarker-based approach to neoadjuvant chemotherapy for muscle-invasive bladder cancer.

BJU Int 2018 09 24;122(3):434-440. Epub 2018 Apr 24.

Division of Hematology and Oncology, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.14220DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126977PMC
September 2018

Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer.

J Clin Oncol 2018 07 9;36(19):1949-1956. Epub 2018 May 9.

Gopa Iyer, Bernard H. Bochner, Guido Dalbagni, S. Machele Donat, Harry W. Herr, Irina Ostrovnaya, Hikmat Al-Ahmadie, Maria E. Arcila, Jamie C. Riches, Andreas Meier, Caitlin Bourque, Maha Shady, Helen Won, Brooke E. Kania, Mariel E. Boyd, Catharine K. Cipolla, Ashley M. Regazzi, Asia S. McCoy, Hebert Alberto Vargas, Michael F. Berger, David B. Solit, Jonathan E. Rosenberg, and Dean F. Bajorin, Memorial Sloan Kettering Cancer Center; Gopa Iyer, Bernard H. Bochner, Guido Dalbagni, S. Machele Donat, Harry W. Herr, Hikmat Al-Ahmadie, David B. Solit, and Dean F. Bajorin, Weill Cornell Medical College; Arjun V. Balar, William C. Huang, Samir S. Taneja, and Daniela Delbeau, New York University Langone Medical Center, New York, NY; and Matthew I. Milowsky, Michael Woods, Tracy L. Rose, and William Y. Kim, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.0158DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6049398PMC
July 2018

Phase II Study of Two Weeks on, One Week off Sunitinib Scheduling in Patients With Metastatic Renal Cell Carcinoma.

J Clin Oncol 2018 06 11;36(16):1588-1593. Epub 2018 Apr 11.

Eric Jonasch, Rebecca S. Slack, Summer Stovall, Donna Juarez, Troy R. Gilchrist, Lisa Pruitt, and Nizar M. Tannir, The University of Texas MD Anderson Cancer Center; Elshad Hasanov, The University of Texas Health Science Center, Houston, TX; Daniel M. Geynisman and Elizabeth R. Plimack, Fox Chase Cancer Center, Philadelphia, PA; Matthew I. Milowsky, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; W. Kimryn Rathmell, Vanderbilt Ingram Cancer Center, Nashville, TN; and Moshe C. Ornstein and Brian I. Rini, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.77.1485
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.77.1485DOI Listing
June 2018

Optimizing Anticancer Therapy in Metastatic Non-Castrate Prostate Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

J Clin Oncol 2018 05 2;36(15):1521-1539. Epub 2018 Apr 2.

Michael J. Morris and Dana Rathkopf, Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine, New York, NY; R. Bryan Rumble, American Society of Clinical Oncology, Alexandria, VA; Ethan Basch and Matthew I. Milowsky, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC; Sebastien J. Hotte, Juravinski Cancer Centre, Hamilton; Andrew Loblaw, Sunnybrook Health Sciences Center, Toronto, Ontario, Canada; Paul Celano, Greater Baltimore Medical Center, Towson, MD; and Rick Bangs, patient representative.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.78.0619DOI Listing
May 2018

Optimizing Anticancer Therapy in Metastatic Non-Castrate Prostate Cancer: ASCO Clinical Practice Guideline Summary.

J Oncol Pract 2018 05 12;14(5):319-322. Epub 2018 Apr 12.

Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine, New York, NY; ASCO, Alexandria, VA; and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00075DOI Listing
May 2018

Intravesical rAd-IFNα/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study.

J Clin Oncol 2017 Oct 23;35(30):3410-3416. Epub 2017 Aug 23.

Neal D. Shore, Carolina Urologic Research Center, Myrtle Beach, SC; Stephen A. Boorjian, Mayo Clinic, Rochester, MN; Daniel J. Canter, Ochsner Health System, New Orleans, LA; Kenneth Ogan, Emory University, Atlanta, GA; Lawrence I. Karsh, The Urology Center of Colorado, Denver, CO; Tracy M. Downs, University of Wisconsin, Madison, WI; Leonard G. Gomella, Thomas Jefferson University, Philadelphia, PA; Ashish M. Kamat and Colin P.N. Dinney, University of Texas MD Anderson Cancer Center; Seth P. Lerner, Baylor College of Medicine, Houston; Yair Lotan, University of Texas Southwestern Medical Center, Dallas; Robert S. Svatek, University of Texas Health Science Center at San Antonio, San Antonio, TX; Trinity J. Bivalacqua, Johns Hopkins School of Medicine, Baltimore, MD; Robert L. Grubb III, Washington University, St Louis, MO; Tracey L. Krupski, University of Virginia, Charlottesville, VA; Michael E. Woods and Matthew I. Milowsky, University of North Carolina, Chapel Hill; Brant A. Inman, Duke University, Durham, NC; Alan Boyd, Alan Boyd Consultants, Cottenham; F. Peter Treasure, Peter Treasure Statistical Services, King's Lynn, United Kingdom; Gillian Gregory, David G. Sawutz, and Nigel R. Parker, FKD Therapies Oy; and Seppo Yla-Herttuala, A.I. Virtanen Institute University of Eastern Finland and Science Service Center and Gene Therapy Unit, Kuopio, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.3064DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648171PMC
October 2017

A Systematic Review of Strategies to Prevent Cisplatin-Induced Nephrotoxicity.

Oncologist 2017 05 24;22(5):609-619. Epub 2017 Apr 24.

Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2016-0319DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423518PMC
May 2017

Checkpoint inhibition: a new beginning for urothelial cancer.

Lancet Oncol 2017 02 10;18(2):160-161. Epub 2017 Jan 10.

Department of Medicine, Division of Hematology/Oncology and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(16)30675-1DOI Listing
February 2017

Reply to vitamin D status may explain racial disparities in survival among patients with advanced renal cell carcinoma in the targeted therapy era.

Cancer 2016 12 14;122(24):3893. Epub 2016 Sep 14.

Division of Hematology/Oncology Department of Medicine, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30343DOI Listing
December 2016

Quality of Life in Long-term Survivors of Muscle-Invasive Bladder Cancer.

Int J Radiat Oncol Biol Phys 2016 12 24;96(5):1028-1036. Epub 2016 Aug 24.

Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2016.08.023DOI Listing
December 2016

Phase 1/2 multiple ascending dose trial of the prostate-specific membrane antigen-targeted antibody drug conjugate MLN2704 in metastatic castration-resistant prostate cancer.

Urol Oncol 2016 12 17;34(12):530.e15-530.e21. Epub 2016 Oct 17.

Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine, Weill Cornell Medical College, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2016.07.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464417PMC
December 2016

Creating a Culture of Safety Within an Institution: Walking the Walk.

J Oncol Pract 2016 10;12(10):880-883

University of North Carolina School of Medicine, and University of North Carolina Hospitals, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2016.012864DOI Listing
October 2016

Racial disparities in survival among patients with advanced renal cell carcinoma in the targeted therapy era.

Cancer 2016 10 24;122(19):2988-95. Epub 2016 Jun 24.

Division of Hematology/Oncology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30146DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030137PMC
October 2016

The Binding Site Barrier Elicited by Tumor-Associated Fibroblasts Interferes Disposition of Nanoparticles in Stroma-Vessel Type Tumors.

ACS Nano 2016 Oct 28;10(10):9243-9258. Epub 2016 Sep 28.

Division of Molecular Pharmaceutics and Center of Nanotechnology in Drug Delivery, Eshelman School of Pharmacy, ‡Lineberger Comprehensive Cancer Center, §Departments of Mathematics and Applied Physical Science, ∥Department of Medicine, ⊥Department of Pathology, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina 27599, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acsnano.6b02776DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515694PMC
October 2016

Sex disparities in use of chemotherapy and survival in patients with advanced bladder cancer.

Cancer 2016 Jul 25;122(13):2012-20. Epub 2016 May 25.

Division of Hematology/Oncology, Department of Medicine, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911298PMC
July 2016

Guideline on Muscle-Invasive and Metastatic Bladder Cancer (European Association of Urology Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement.

J Clin Oncol 2016 06 21;34(16):1945-52. Epub 2016 Mar 21.

Matthew I. Milowsky, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; R. Bryan Rumble, American Society of Clinical Oncology, Alexandria, VA; Christopher M. Booth, Queen's University, Kingston; Libni J. Eapen, Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada; Timothy Gilligan, Cleveland Clinic, Cleveland, OH; Ralph J. Hauke, Nebraska Cancer Specialists, Omaha, NE; Pat Boumansour, Patient Representative, Palm Coast, FL; and Cheryl T. Lee, University of Michigan, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.9797DOI Listing
June 2016

Improving Systemic Chemotherapy for Bladder Cancer.

Curr Oncol Rep 2016 May;18(5):27

Division of Hematology/Oncology, Department of Medicine, University of North Carolina Lineberger Comprehensive Cancer Center, 170 Manning Drive, CB #7295, 27599, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-016-0512-2DOI Listing
May 2016

Intrinsic Genomic Differences Between African American and White Patients With Clear Cell Renal Cell Carcinoma.

JAMA Oncol 2016 May;2(5):664-667

Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill2Department of Medicine, Division of Hematology/Oncology, University of North Carolina at Chapel Hill, Chapel Hill3Department of Urology, University of North C.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.0005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035632PMC
May 2016

A Small Step Toward Improving Systemic Treatment for Metastatic Bladder Cancer--At What Cost?

Eur Urol 2016 Apr 4;69(4):642-644. Epub 2015 Sep 4.

Department of Medicine, Division of Hematology and Medical Oncology, University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, NC, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2015.08.039DOI Listing
April 2016

Stage at presentation and survival outcomes of patients with Gleason 8-10 prostate cancer and low prostate-specific antigen.

Urol Oncol 2016 Mar 29;34(3):119.e19-26. Epub 2015 Oct 29.

Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC; University of North Carolina-Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10781439150047
Publisher Site
http://dx.doi.org/10.1016/j.urolonc.2015.09.014DOI Listing
March 2016

Genomic profiling of advanced bladder cancer to guide the use of targeted therapeutics.

Cancer 2016 Mar 9;122(5):676-7. Epub 2015 Dec 9.

Division of Hematology/Oncology, Department of Medicine, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29825DOI Listing
March 2016

Phase I Study of Everolimus in Combination with Gemcitabine and Split-Dose Cisplatin in Advanced Urothelial Carcinoma.

Bladder Cancer 2016 Jan 7;2(1):111-117. Epub 2016 Jan 7.

Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/BLC-150038DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927849PMC
January 2016

The geriatrics and genetics behind bladder cancer.

Am Soc Clin Oncol Educ Book 2014 :e192-5

From the Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2014.34.e192DOI Listing
November 2015

Improving Patient Safety in Clinical Oncology: Applying Lessons From Normal Accident Theory.

JAMA Oncol 2015 Oct;1(7):958-64

Department of Radiation Oncology, University of North Carolina School of Medicine, Chapel Hill2Lineberger Comprehensive Cancer Center, University of North Carolina Hospitals, Chapel Hill.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.0891DOI Listing
October 2015

Management of muscle-invasive bladder cancer in the elderly.

Curr Opin Urol 2015 Sep;25(5):459-67

Division of Hematology/Oncology, Department of Medicine, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOU.0000000000000190DOI Listing
September 2015

Metachronous Bilateral Testicular Leydig-Like Tumors Leading to the Diagnosis of Congenital Adrenal Hyperplasia (Adrenogenital Syndrome).

Case Rep Pathol 2015 16;2015:459318. Epub 2015 Aug 16.

Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599, USA ; Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2015/459318DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553183PMC
September 2015

Neoadjuvant therapy in muscle-invasive bladder cancer: a model for rational accelerated drug development.

Urol Clin North Am 2015 May 11;42(2):217-24, viii-ix. Epub 2015 Mar 11.

Genitourinary Oncology, Urologic Oncology Program, UNC Lineberger Comprehensive Cancer Center, 3rd Floor Physician's Office Building, 170 Manning Drive, Chapel Hill, NC 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ucl.2015.02.004DOI Listing
May 2015

Multidisciplinary care of the urothelial cancer patient.

Urol Clin North Am 2015 May;42(2):xiii

Genitourinary Oncology, Urologic Oncology Program, UNC Lineberger Comprehensive Cancer Center, Division of Hematology/Oncology, 3rd Floor, Physician's Office Building, 170 Manning Drive, Chapel Hill, NC 27599, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ucl.2015.03.001DOI Listing
May 2015

Comparative effectiveness of mitoxantrone plus prednisone versus prednisone alone in metastatic castrate-resistant prostate cancer after docetaxel failure.

Oncologist 2015 May 17;20(5):516-22. Epub 2015 Apr 17.

UNC Lineberger Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, and Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0432DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425389PMC
May 2015

Cytotoxic and DNA-targeted therapy in urothelial cancer: have we squeezed the lemon enough?

Cancer 2015 Jan 4;121(2):179-87. Epub 2014 Aug 4.

Genitourinary Cancers Program, Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28754DOI Listing
January 2015

Concurrent chemoradiotherapy for men with locally advanced penile squamous cell carcinoma.

Clin Genitourin Cancer 2014 Dec 27;12(6):440-6. Epub 2014 Mar 27.

University of Alabama at Birmingham (UAB) Comprehensive Cancer Center, Birmingham, AL. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2014.03.009DOI Listing
December 2014

Is extending surveillance guidelines for renal cell carcinoma without understanding patient outcomes putting the cart before the horse?

J Clin Oncol 2014 Dec 17;32(36):4031-2. Epub 2014 Nov 17.

University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.58.3195DOI Listing
December 2014

Muscle-invasive bladder cancer: evaluating treatment and survival in the National Cancer Data Base.

BJU Int 2014 Nov 16;114(5):719-26. Epub 2014 Apr 16.

Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Lineberger Comprehensive Cancer Center, Multidisciplinary Genitourinary Oncology, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.12601DOI Listing
November 2014

Arrays of High-Aspect Ratio Microchannels for High-Throughput Isolation of Circulating Tumor Cells (CTCs).

Microsyst Technol 2014 Oct;20(10-11):1815-1825

Department of Biomedical Engineering, University of North Carolina, Chapel Hill, NC, USA ; Department of Chemistry, University of North Carolina, Chapel Hill, NC, USA ; Lineberger Comprehensive Cancer Center, UNC School of Medicine, Chapel Hill, NC, USA ; BioFluidica, Inc., Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00542-013-1941-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207852PMC
October 2014

Neoadjuvant chemotherapy for bladder cancer does not increase risk of perioperative morbidity.

BJU Int 2014 Aug 14;114(2):221-8. Epub 2014 Mar 14.

Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.12585DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033705PMC
August 2014

Association of hospital volume with conditional 90-day mortality after cystectomy: an analysis of the National Cancer Data Base.

BJU Int 2014 Jul 22;114(1):46-55. Epub 2014 May 22.

University of North Carolina Lineberger Comprehensive Cancer Center, USA; Department of Urology, University of North Carolina School of Medicine, USA; Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.12566DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019706PMC
July 2014

Neoadjuvant paradigm for accelerated drug development: an ideal model in bladder cancer.

Oncologist 2013 24;18(8):933-40. Epub 2013 Jul 24.

Department of Medicine, Division of Hematology and Oncology, University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2013-0023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755931PMC
May 2014

Highlights from the first symposium on upper tract urothelial carcinoma.

Urol Oncol 2014 Apr 4;32(3):309-16. Epub 2014 Jan 4.

Zickler Laboratory of Chemical Biology, Health Sciences Center, Stony Brook University, Stony Brook, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2013.08.029DOI Listing
April 2014

Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology.

Proc Natl Acad Sci U S A 2014 Feb 11;111(8):3110-5. Epub 2014 Feb 11.

Department of Genetics, Department of Medicine, Division of Hematology/Oncology, Department of Surgery, Department of Pathology and Laboratory Medicine, and Department of Pharmacology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1318376111DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3939870PMC
February 2014

Trends in stage-specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006.

Cancer 2014 Jan 10;120(1):86-95. Epub 2013 Oct 10.

Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina; Department of Urology, University of North Carolina School of Medicine, Chapel Hill, North Carolina; Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.28397
Publisher Site
http://dx.doi.org/10.1002/cncr.28397DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964001PMC
January 2014

Phase II study of Lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer.

Clin Cancer Res 2013 Sep 28;19(18):5182-91. Epub 2013 May 28.

Authors' Affiliations: Weill Cornell Medical College (WCMC); Weill Cornell Cancer Center; Memorial Sloan-Kettering Cancer Center (MSKCC), New York, New York; and University of North Carolina Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-0231DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778101PMC
September 2013

Phase II study of everolimus in metastatic urothelial cancer.

BJU Int 2013 Aug 3;112(4):462-70. Epub 2013 Apr 3.

Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2012.11720.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020005PMC
August 2013

Tools to improve clinical trial design in urothelial cancer.

Cancer 2013 Aug 29;119(16):2950-2. Epub 2013 May 29.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28176DOI Listing
August 2013

Optimizing systemic therapy for bladder cancer.

J Natl Compr Canc Netw 2013 Jul;11(7):793-804

Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, California 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2013.0101DOI Listing
July 2013

Fibroblast growth factor receptor-3 in urothelial tumorigenesis.

Urol Oncol 2013 Apr 30;31(3):303-11. Epub 2012 Jan 30.

Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2011.12.001DOI Listing
April 2013

Prognostic model for predicting survival of patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy.

J Natl Cancer Inst 2013 Apr 14;105(7):499-503. Epub 2013 Feb 14.

Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691944PMC
April 2013

Advanced urothelial carcinoma: moving the field forward.

Oncology (Williston Park) 2013 Mar;27(3):233-4, C3

Department of Medicine, Division of Hematology and Medical Oncology, University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA.

View Article

Download full-text PDF

Source
March 2013

Challenges in recognizing treatment-related neuroendocrine prostate cancer.

J Clin Oncol 2012 Dec 19;30(36):e386-9. Epub 2012 Nov 19.

Weill Cornell Cancer Center; Weill Cornell Medical College, New York, NY, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2011.41.5166
Publisher Site
http://dx.doi.org/10.1200/JCO.2011.41.5166DOI Listing
December 2012

Novel agents in invasive urothelial cancer.

Clin Adv Hematol Oncol 2012 Aug;10(8):504-16

Memorial Sloan-Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
August 2012

Novel molecular targets for the therapy of urothelial carcinoma.

Expert Opin Ther Targets 2012 May 18;16(5):499-513. Epub 2012 Apr 18.

University of Texas Medical Branch , Galveston, TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14728222.2012.677441DOI Listing
May 2012

Regional lymph node status in patients with bladder cancer found to be pathological stage T0 at radical cystectomy following systemic chemotherapy.

BJU Int 2011 Oct 14;108(8 Pt 2):E272-7. Epub 2011 Feb 14.

Department of Surgery, Urology Section, Memorial Sloan-Kettering Cancer Center, 1275 York Ave Box 213, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2010.09981.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319321PMC
October 2011

Management of invasive bladder cancer in patients who are not candidates for or decline cystectomy.

Ther Adv Urol 2011 Jun;3(3):107-17

Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1756287211407543DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159398PMC
June 2011

Transitional cell carcinoma of the bladder: racial and gender disparities in survival (1993 to 2002), stage and grade (1993 to 2007).

J Urol 2011 May 21;185(5):1631-6. Epub 2011 Mar 21.

American College of Surgeons, Chicago, Illinois 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2010.12.049DOI Listing
May 2011

Hypoxia-inducible factor and mammalian target of rapamycin pathway markers in urothelial carcinoma of the bladder: possible therapeutic implications.

BJU Int 2011 Mar 12;107(5):844-849. Epub 2010 Aug 12.

Department of PathologyGenitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer CenterWeill Cornell Medical College of Cornell UniversityDepartment of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer, Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2010.09517.xDOI Listing
March 2011

Novel strategies for treating relapsed/refractory urothelial carcinoma.

Expert Rev Anticancer Ther 2010 Dec;10(12):1917-32

Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/era.10.182DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705930PMC
December 2010

Radical cystectomy in octogenarians--does morbidity outweigh the potential survival benefits?

J Urol 2010 Jun;183(6):2171-7

Department of Urology, the Genitourinary Oncology Service in the Department of Medicine (MIM), and the Department of Epidemiology and Biostatistics (AC), Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2010.02.015DOI Listing
June 2010

Phase II study of sunitinib in patients with metastatic urothelial cancer.

J Clin Oncol 2010 Mar 8;28(8):1373-9. Epub 2010 Feb 8.

Genitourinary OncologyService, Division of Solid Tumor Oncology,and the Departments of Radiology,Medicine, Memorial Sloan-Kettering Cancer Center,New York, NY, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.25.3922DOI Listing
March 2010

Sequential adjuvant chemotherapy after surgical resection of high-risk urothelial carcinoma.

Cancer 2009 Nov;115(22):5193-201

Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.24570DOI Listing
November 2009

Final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urothelium.

J Clin Oncol 2009 Sep 27;27(25):4062-7. Epub 2009 Jul 27.

Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.21.2241DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979229PMC
September 2009

Bladder cancer.

Curr Treat Options Oncol 2009 Aug;10(3-4):205-15

Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, 1275 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11864-009-0112-6
Publisher Site
http://dx.doi.org/10.1007/s11864-009-0112-6DOI Listing
August 2009

Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000.

Cancer 2009 Apr;115(7):1435-47

Department of Medicine, Weill Cornell Medical College of Cornell University, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.24147DOI Listing
April 2009